Robert Azerad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert Azerad has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
F Acher
5 shared publicationsC Ferradini
Laboratoire de Chimie-Physique
3 shared publicationsM Gardès-Albert
Laboratoire de Chimie-Physique
3 shared publicationsD Jore
Laboratoire de Chimie-Physique
2 shared publicationsL Fackir
Laboratoire de Chimie-Physique
2 shared publicationsV Larue
René Descartes-Paris V University, Laboratory of Pharmacological and Toxicological Chemistry and Biochemistry (URA 400 CNRS), Paris, France
2 shared publications
Latest Publications
- 1 September 1999
- Published by Elsevier in Phytochemistry
- Vol. 52 (2) , 291-296
Microbial hydroxylation of natural drimenic lactones
- 1 September 1999
- Published by Elsevier in Phytochemistry
- Vol. 52 (2) , 291-296
Microbial hydroxylation of natural drimenic lactones
- 1 January 1999
- Published by Springer Nature
- Vol. 63, 169-218
Microbial Models for Drug Metabolism
This review describes microbial transformation studies of drugs, comparing them with the corresponding metabolism in animal systems, and providing technical methods for developing microbial models. Emphasis is laid on the potential for selected microorganisms to mimic all patterns of mammalian biotransformations and to provide preparative methods for structural identification and toxicological and pharmacological studies of drug metabolites.
- 1 January 1999
- Published by Springer Nature
- Vol. 63, 169-218
Microbial Models for Drug Metabolism
This review describes microbial transformation studies of drugs, comparing them with the corresponding metabolism in animal systems, and providing technical methods for developing microbial models. Emphasis is laid on the potential for selected microorganisms to mimic all patterns of mammalian biotransformations and to provide preparative methods for structural identification and toxicological and pharmacological studies of drug metabolites.
- 1 July 1997
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 5 (7) , 1369-1380
Microbial biotransformations of a synthetic immunomodulating agent, HR325
- 1 July 1997
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 5 (7) , 1369-1380
Microbial biotransformations of a synthetic immunomodulating agent, HR325
- 12 June 1997
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 8 (11) , 1735-1739
Dynamic kinetic resolution in the microbial reduction of α-monosubstituted β-oxoesters: the reduction of 2-carbethoxycycloheptanone and 2-carbethoxy-cyclooctanone
- 12 June 1997
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 8 (11) , 1735-1739
Dynamic kinetic resolution in the microbial reduction of α-monosubstituted β-oxoesters: the reduction of 2-carbethoxycycloheptanone and 2-carbethoxy-cyclooctanone
- 1 January 1997
- Vol. 49 (1) , 28-45
Vitamin K-dependent carboxylase. In vitro inhibitory activity of cyclopentane and cyclohexane-derived analogues of glutamic acid and their conformational study by NMR and molecular dynamics in aqueous solution.
The conformational analysis of four glutamic acid analogues containing a cyclopentyl or cyclohexyl ring, substituted in position 1 by a Boc-protected amino group and a methyl ester group and in position 3 by a free carboxylate group (6-9), has been carried out in an aqueous environment, by 1H and 13C NMR spectroscopy, and molecular dynamics (MD). These compounds have been shown to be weak competitive inhibitors (Ki approximately 20-65 mM) of the vitamin K-dependent carboxylation of Boc-Glu-OMe in rat liver microsomes independently of their ring size and stereochemical features. However, the cyclic trans isomers have been found more active than the cis ones, and Boc-trans-C5-OMe (9) is the most potent inhibitor in the series (cis and trans isomers are defined by the relative arrangement of the carboxyl functions). Such cyclic glutamyl derivatives may provide valuable informations on the preferred bioactive conformations of synthetic glutamyl substrates at the active site of the carboxylase. In aqueous solution, the Boc-cis- and trans-C6 esters exhibit chair conformations with exclusively equatorial and axial substituent positions, while the Boc-cis- and -trans-C5 compounds may display envelope E or 'twist' T conformations with the substituents in the following positions, equatorial; axial and isoclinal. For each compound, the conformations resulting from NMR and MD data were analyzed and classified according to the dihedral angles chi 1 and chi 2, the distances of functional groups, and the spatial charge distribution involving the free carboxyl group. A reduced number of conformational families were found to be in qualitative agreement with NMR and MD data. These results are discussed in relation with the carboxylase inhibitory activity of the analogues, and a spatial disposition of the glutamyl side chain that could be recognized by the carboxylase is deduced.
- 1 January 1997
- Vol. 49 (1) , 28-45
Vitamin K-dependent carboxylase. In vitro inhibitory activity of cyclopentane and cyclohexane-derived analogues of glutamic acid and their conformational study by NMR and molecular dynamics in aqueous solution.
The conformational analysis of four glutamic acid analogues containing a cyclopentyl or cyclohexyl ring, substituted in position 1 by a Boc-protected amino group and a methyl ester group and in position 3 by a free carboxylate group (6-9), has been carried out in an aqueous environment, by 1H and 13C NMR spectroscopy, and molecular dynamics (MD). These compounds have been shown to be weak competitive inhibitors (Ki approximately 20-65 mM) of the vitamin K-dependent carboxylation of Boc-Glu-OMe in rat liver microsomes independently of their ring size and stereochemical features. However, the cyclic trans isomers have been found more active than the cis ones, and Boc-trans-C5-OMe (9) is the most potent inhibitor in the series (cis and trans isomers are defined by the relative arrangement of the carboxyl functions). Such cyclic glutamyl derivatives may provide valuable informations on the preferred bioactive conformations of synthetic glutamyl substrates at the active site of the carboxylase. In aqueous solution, the Boc-cis- and trans-C6 esters exhibit chair conformations with exclusively equatorial and axial substituent positions, while the Boc-cis- and -trans-C5 compounds may display envelope E or 'twist' T conformations with the substituents in the following positions, equatorial; axial and isoclinal. For each compound, the conformations resulting from NMR and MD data were analyzed and classified according to the dihedral angles chi 1 and chi 2, the distances of functional groups, and the spatial charge distribution involving the free carboxyl group. A reduced number of conformational families were found to be in qualitative agreement with NMR and MD data. These results are discussed in relation with the carboxylase inhibitory activity of the analogues, and a spatial disposition of the glutamyl side chain that could be recognized by the carboxylase is deduced.
- Open Access
- 1 January 1995
- Published by EDP Sciences in Journal de Chimie Physique et de Physico-Chimie Biologique
- Vol. 92, 1809-1812
ACPD ligands for glutamic receptors : conformational analysis by NMR spectroscopy and molecular dynamics. Simulation in water of glutamic acid analogues containing a cyclopentane ring
- 1 January 1995
- Published by EDP Sciences in Journal de Chimie Physique et de Physico-Chimie Biologique
- Vol. 92, 1809-1812
Open AccessACPD ligands for glutamic receptors : conformational analysis by NMR spectroscopy and molecular dynamics. Simulation in water of glutamic acid analogues containing a cyclopentane ring
- Open Access
- 1 January 1994
- Published by EDP Sciences in Journal de Chimie Physique et de Physico-Chimie Biologique
- Vol. 91, 1048-1053
Radioréduction de la vitamine K en solution éthanolique
- 1 January 1994
- Published by EDP Sciences in Journal de Chimie Physique et de Physico-Chimie Biologique
- Vol. 91, 1048-1053
Open AccessRadioréduction de la vitamine K en solution éthanolique
- Open Access
- 1 January 1993
- Published by EDP Sciences in Journal de Chimie Physique et de Physico-Chimie Biologique
- Vol. 90, 815-825
Étude radiolytique de l'oxydation d'un modèle de vitamine K en solution éthanolique
- 1 January 1993
- Published by EDP Sciences in Journal de Chimie Physique et de Physico-Chimie Biologique
- Vol. 90, 815-825
Open AccessÉtude radiolytique de l'oxydation d'un modèle de vitamine K en solution éthanolique
- Open Access
- 1 January 1991
- Published by EDP Sciences in Journal de Chimie Physique et de Physico-Chimie Biologique
- Vol. 88, 955-966
Activation radicalaire d’un modèle de vitamine K par les radicaux OH • et N 3• . Étude par radiolyse γ
- 1 January 1991
- Published by EDP Sciences in Journal de Chimie Physique et de Physico-Chimie Biologique
- Vol. 88, 955-966
Open AccessActivation radicalaire d’un modèle de vitamine K par les radicaux OH • et N 3• . Étude par radiolyse γ